Our Services
Medical Information
Helpful Resources
Published on: 9/24/2026
Common side effects of Zoloft (sertraline) in women include nausea, diarrhea or upset stomach, headache, drowsiness or insomnia, dry mouth, increased sweating, dizziness, appetite and weight changes, and sexual side effects such as reduced libido or difficulty reaching orgasm. Some women also report menstrual cycle changes, breast tenderness, worsened premenstrual symptoms, or fatigue, and many of these effects ease within the first few weeks as the body adjusts. Certain symptoms matter more than others, including serious warning signs and considerations during pregnancy or breastfeeding, so review the complete details below before deciding what to do next.
Because side effects can overlap with anxiety, depression, hormonal shifts, or other conditions, it is easy to misread what your body is telling you. A free, instant, online symptom check can help you sort out whether what you are feeling is likely medication related or something that deserves a closer look, and it points you toward the right next step in minutes.
Last reviewed for medical accuracy: 09/24/2026
Zoloft (sertraline) is a widely prescribed selective serotonin reuptake inhibitor (SSRI) used to treat depression, anxiety disorders, and other mood conditions. When used as zoloft for depression, it can help restore chemical balance in the brain, improving mood, sleep, and overall well-being. While many women tolerate Zoloft well, it can cause side effects that range from mild and short-lived to more serious. Understanding these potential reactions can help you manage them and know when to seek medical attention.
Many women experience one or more of the following side effects, especially during the first few weeks of treatment or after a dose increase. In most cases, these improve as your body adjusts.
Tips to manage:
Tips to manage:
Tips to manage:
Tips to manage:
Tips to manage:
Some side effects are less frequent but still reported. If any of these persist or worsen, let your healthcare provider know.
While most women tolerate Zoloft well, watch for these less common but potentially serious reactions. Seek immediate medical attention if you experience:
If you notice any of these symptoms, stop taking Zoloft and call emergency services or go to the nearest emergency department.
Start Low, Go Slow
Your doctor may begin at a lower dose and increase gradually to reduce side effects.
Consistent Timing
Take Zoloft at the same time each day. Adjust morning versus evening dosing based on how it affects your sleep and energy.
Hydration and Diet
Drink plenty of water. Eat balanced meals rich in fiber, lean protein, fruits, and vegetables.
Exercise and Relaxation
Regular moderate exercise can ease fatigue and boost mood. Incorporate relaxation techniques like yoga or guided imagery.
Track and Communicate
Keep a simple chart of when you take each dose and note any side effects. Share this with your healthcare provider at follow-up visits.
You may consider doing a free, online symptom check, using the doctor approved Ubie Symptom Checker to better understand and track any symptoms you’re experiencing. This tool can guide you on when to manage side effects at home and when to seek professional help.
Always consult your prescribing physician before stopping or changing your dose. Abruptly stopping Zoloft can cause withdrawal symptoms such as dizziness, irritability, flu-like sensations, and sleep disturbances.
Zoloft for depression can be highly effective in improving mood, reducing anxiety, and restoring daily functioning. While side effects are possible, most women find they diminish over time or can be managed with simple adjustments. Open communication with your healthcare provider, careful monitoring, and lifestyle support play key roles in maximizing benefits and minimizing discomfort.
If you ever experience serious or life-threatening symptoms, please seek immediate medical attention. For any concerns—big or small—speak to your doctor. They can tailor your treatment plan to help you feel your best.
(References)
* Lau GT, Horowitz BZ. Sertraline overdose. Acad Emerg Med. 1996 Feb;3(2):132-6. doi: 10.1111/j.1553-2712.1996.tb03400.x. PMID: 8808373.
* DeVane CL, Liston HL, Markowitz JS. Clinical pharmacokinetics of sertraline. Clin Pharmacokinet. 2002;41(15):1247-66. doi: 10.2165/00003088-200241150-00002. PMID: 12452737.
* Kaufman KR, Podolsky D, Greenman D, Madraswala R. Antidepressant-selective gynecomastia. Ann Pharmacother. 2013 Jan;47(1):e6. doi: 10.1345/aph.1R491. Epub 2013 Jan 16. PMID: 23324513.
* Gatto EM, Aldinio V, Parisi V, Persi G, Da Prat G, Bullrich MB, Sanchez P, Rojas G. Sertraline-induced Hemichorea. Tremor Other Hyperkinet Mov (N Y). 2017;7:518. doi: 10.7916/D8XK999F. Epub 2017 Dec 18. PMID: 29276648; PMCID: PMC5740228.
* Virdee G, Bleasdale J, Ikramullah M, Graham-Clarke E. Sertraline-induced hypersensitivity pneumonitis. BMJ Case Rep. 2019 Dec 19;12(12). doi: 10.1136/bcr-2019-230724. Epub 2019 Dec 19. PMID: 31862812; PMCID: PMC6936525.
* Revet A, Montastruc F, Roussin A, Raynaud JP, Lapeyre-Mestre M, Nguyen TTH. Antidepressants and movement disorders: a postmarketing study in the world pharmacovigilance database. BMC Psychiatry. 2020 Jun 16;20(1):308. doi: 10.1186/s12888-020-02711-z. Epub 2020 Jun 16. PMID: 32546134; PMCID: PMC7298955.
* Strawn JR, Mills JA, Poweleit EA, Ramsey LB, Croarkin PE. Adverse Effects of Antidepressant Medications and their Management in Children and Adolescents. Pharmacotherapy. 2023 Jul;43(7):675-690. doi: 10.1002/phar.2767. Epub 2023 Jan 27. PMID: 36651686; PMCID: PMC10378577.
* Luo X, Zhu D, Li J, Ren M, Liu Y, Si T, Chen Y. Selection of the optimal dose of sertraline for depression: A dose-response meta-analysis of randomized controlled trials. Psychiatry Res. 2023 Sep;327:115391. doi: 10.1016/j.psychres.2023.115391. Epub 2023 Aug 1. PMID: 37557058.
* Yan N, Hu S. The safety and efficacy of escitalopram and sertraline in post-stroke depression: a randomized controlled trial. BMC Psychiatry. 2024 May 15;24(1):365. doi: 10.1186/s12888-024-05833-w. Epub 2024 May 15. PMID: 38750479; PMCID: PMC11094958.
* Jespersen C, Lauritsen MP, Frokjaer VG, Schroll JB. Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder. Cochrane Database Syst Rev. 2024 Aug 14;8(8):CD001396. doi: 10.1002/14651858.CD001396.pub4. Epub 2024 Aug 14. PMID: 39140320; PMCID: PMC11323276.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.